Children as young as 6 months could soon be eligible for the COVID-19 vaccine if federal regulators agree the shots are safe and effective.
[vc_row][vc_column][us_carousel post_type="ids" ids="260184, 260250, 107361" orderby="post__in" items_quantity="3" items_layout="11024" columns="3" items_gap="5px" overriding_link="post" breakpoint_1_cols="4" breakpoint_2_cols="3" breakpoint_3_cols="2"][/vc_column][/vc_row]
{
"slotId": "7483666091",
"unitType": "in-article",
"pubId": "pub-9300059770542025"
}
Pfizer/BioNTech this week asked the U.S. Food and Drug Administration to approve two doses for children ages 6 months to 4 years old, with the expectation that a third dose would be needed shortly thereafter. The vaccine is already available for children 5 and up.
Here’s everything you need to know about the process:
How soon could the vaccine be available to children under age 5?
What has Pfizer’s pediatric clinical trials shown?
Why is a vaccine for children this young necessary?
Will young children be given the same amount of vaccine as older children or adults?
Will parents ultimately get their youngest children vaccinated?
